Literature DB >> 24426210

Total serum immunoglobulin e in children with asthma.

M Lama1, M Chatterjee2, T K Chaudhuri3.   

Abstract

Immunoglobulin (Ig) E has been shown to be a major contributing factor for the development of bronchial hyperresponsiveness in asthma. An elevation in serum IgE levels contributes to asthma and is considered a potent predictor of the development of asthma. The objectives of the present study were to estimate the levels of total serum IgE in asthmatic and healthy control subjects and to investigate the relationship of various demographic and clinical characteristics with the total serum IgE level in asthmatics. We measured the levels of total serum IgE using the ELISA kits (AccuBind, Monobind Inc., USA). The relevant demographic and clinical data were obtained using the questionnaire. The results showed that asthmatic children had significantly elevated level of total serum IgE compared to that of the healthy controls. The levels of total IgE and IL-4 in sera of 44 asthmatic children showed a significant positive correlation. Total serum IgE >150 IU/mL was found to be significantly associated with the age, exposure to cigarette smoke, and raised eosinophil count in asthmatic children. In conclusion, the elevated level of total serum IgE may demonstrate the allergic etiology of asthma in the subjects studied.

Entities:  

Keywords:  Asthma; Children; Eosinophil; Immunoglobulin E; Interleukin-4

Year:  2012        PMID: 24426210      PMCID: PMC3613494          DOI: 10.1007/s12291-012-0247-2

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  14 in total

1.  Association of the expression of IL-4 and IL-13 genes, IL-4 and IgE serum levels with allergic asthma.

Authors:  Jalil Tavakkol Afshari; Reza Farid Hosseini; Sara Hosseini Farahabadi; Farhad Heydarian; Mohammad Hossein Boskabady; Rasoul Khoshnavaz; Alireza Razavi; Ehsan Ghayoor Karimiani; Gholamreza Ghasemi
Journal:  Iran J Allergy Asthma Immunol       Date:  2007-06       Impact factor: 1.464

2.  Host factors and environmental determinants associated with skin test reactivity and eosinophilia in a community-based population study.

Authors:  T T Mensinga; J P Schouten; B Rijcken; S T Weiss; R van der Lende
Journal:  Ann Epidemiol       Date:  1994-09       Impact factor: 3.797

3.  Total serum immunoglobulin E levels in a case-control study in asthmatic/allergic patients, their family members, and healthy subjects from India.

Authors:  S Sharma; P C Kathuria; C K Gupta; K Nordling; B Ghosh; A B Singh
Journal:  Clin Exp Allergy       Date:  2006-08       Impact factor: 5.018

4.  Distribution of allergy in a population sample residing in Tucson, Arizona.

Authors:  M G Cline; B Burrows
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

5.  IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.

Authors:  G Del Prete; E Maggi; P Parronchi; I Chrétien; A Tiri; D Macchia; M Ricci; J Banchereau; J De Vries; S Romagnani
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

6.  Relationship among asthma, serum IgE levels and skin test sensitivity to inhaled allergens.

Authors:  L R Freidhoff; D G Marsh
Journal:  Int Arch Allergy Immunol       Date:  1993       Impact factor: 2.749

Review 7.  Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children.

Authors:  D P Strachan; D G Cook
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

8.  Evaluation of serum immunoglobulin E levels in bronchial asthma.

Authors:  Thirunavukkarasu Sandeep; Mysore Subrahmanyam Roopakala; Chickballapur Rayappa Wilma Delphine Silvia; Srikantaiah Chandrashekara; Mohan Rao
Journal:  Lung India       Date:  2010-07

9.  Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children.

Authors:  M R Sears; B Burrows; E M Flannery; G P Herbison; C J Hewitt; M D Holdaway
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

10.  Is serum total IgE levels a good predictor of allergies in children?

Authors:  Hema Satwani; Arshalooz Rehman; Sohail Ashraf; Anwar Hassan
Journal:  J Pak Med Assoc       Date:  2009-10       Impact factor: 0.781

View more
  6 in total

1.  Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat.

Authors:  Nuria Renata Roldán; Mariela Jiménez; Daniel Cervantes-García; Estefanía Marín; Eva Salinas
Journal:  Inflamm Res       Date:  2016-01-11       Impact factor: 4.575

Review 2.  The immunomodulatory effect of acupoint application for childhood asthma: a systematic review and meta-analysis.

Authors:  Xiao Cun Yang; Tao Yin; Qian Gao; Ling Jun Kong
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-27       Impact factor: 2.629

3.  Association between IL-13 +1923C/T polymorphism and asthma risk: a meta-analysis based on 26 case-control studies.

Authors:  Yueli Xu; Junjuan Li; Zhaolei Ding; Juan Li; Bin Li; Zhengang Yu; Wei Tan
Journal:  Biosci Rep       Date:  2017-01-27       Impact factor: 3.840

Review 4.  Asthma biomarkers in the age of biologics.

Authors:  Harold Kim; Anne K Ellis; David Fischer; Mary Noseworthy; Ron Olivenstein; Kenneth R Chapman; Jason Lee
Journal:  Allergy Asthma Clin Immunol       Date:  2017-11-17       Impact factor: 3.406

5.  Assessment of Acupoint Therapy of Traditional Chinese Medicine on Cough Variant Asthma: A Meta-analysis.

Authors:  Hengjia Tu; Qingling Zhang
Journal:  Biomed Res Int       Date:  2022-07-30       Impact factor: 3.246

6.  Suboptimal Serum 25-Hydroxy-Vitamin D Is Associated with a History of Recent Disease Exacerbation in Pediatric Patients with Bronchial Asthma or Asthma-Suggestive Recurrent Wheezing.

Authors:  Teodora-Irina Adam-Bonci; Paraschiva Cherecheș-Panța; Eduard-Alexandru Bonci; Sorin Claudiu Man; Ancuța Cutaș-Benedec; Tudor Drugan; Raluca Maria Pop; Alexandru Irimie
Journal:  Int J Environ Res Public Health       Date:  2020-09-09       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.